Marketzone with MT Newswires 2022 | All the news about VERTEX PHARMACEUTICALS |
| | |
| Analyst recommendations on VERTEX PHARMACEUTICALS |
| | |
|
|
| 2022 turnover |
8,711M
–
8,577M | | 2022 net result |
3,167M
–
3,119M | | trso. net 2022 |
10,836M
–
10,669M | | PER 2022 | 22.8x | | 2022 return | – |
| | Capitalization |
70,362M
70,362M
69,278M | | VE / CA 2022 | 6.83x | | VE / CA 2023 | 5.96x | | Number of employees | 3,900 | | Floating | 99.8% |
|
| Chart VERTEX PHARMACEUTICALS |
|
Hard :
Period:
|
 | |
Trending technical analysis VERTEX PHARMACEUTICALS
| Short term | Middle term | Long term | | Trends | Bearish | bullish | bullish | Evolution of the Income Statement | | Average recommendation | ACCUMULATE | | Number of Analysts | 27 | | Last Closing Price | $288.03 | | Average price target | $308.68 | | Deviation / Average Target | 7.17% |
|
Source link -88
